Overview

Bispectral Index-guided Sedation for Flexible Bronchoscopy

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
With the advances of flexible bronchoscopy, like metallic stent, electrocautery and real time endobronchial ultrasound, the complexity and duration of procedures are increasing. So, adequate sedation and analgesia is important for both patients and bronchoscopist. Clinical-judged midazolam administration is the current standard. However, midazolam is difficult to titrated and the clinical observations are not reliable sedative indices. Propofol is titrated easily because of its unique pharmacokinetics. Bispectral index (BIS), a real time monitor of depth-of-sedation, has been applied in general anesthesia. We design a BIS-guided propofol sedation for bronchoscopy. Through the combination of advantages of propofol and BIS, we hope to provide patients a more tolerable and safety sedation for bronchoscopy.
Phase:
Phase 4
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Treatments:
Alfentanil
Midazolam
Propofol